Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
31 October 2014

 
30 October 2014
In the fifth instalment of Clinica’s new reimbursement series, Dr Mark Charny explains that careful and detailed consideration of the reimbursement, prescribing and purchasing regulations in each market is required to develop a coherent marketing ...
29 October 2014
A small group of experts is to conduct an independent assessment of Australia's Therapeutic Goods Administration with a view to streamlining the agency's regulatory processes for medicines and medical devices, improving access to medicines, and ...
28 October 2014
Two extremity implant makers, Wright Medical and Tornier, are set to merge in a $3.3bn all-stock transaction. The deal will create a “mid-sized growth company” with a presence in the “fastest growing areas of orthopedics – upper extremities, lower ...
28 October 2014
The European medical devices sector urgently needs transparency on future regulations to start preparing for the new requirements. However, no one can yet confirm just how long it will take the European institutions to agree on the final texts of ...
 
30 October 2014
Abbott Laboratories, already among the most diversified major medtech companies, is now entering the electrophysiology space. With the acquisition of Topera Medical and the rights to buy Advanced Cardiac Therapeutics, Abbott is going after the ...
30 October 2014
Laboratory Corporation of America (LabCorp) had a solid third-quarter, according to Goldman Sachs’ Isaac Ro, again beating analyst predictions. Sales of $1.55bn grew 6% year-on-year and were above consensus of $1.50bn; while adjusted earnings of ...
29 October 2014
A small group of experts is to conduct an independent assessment of Australia's Therapeutic Goods Administration with a view to streamlining the agency's regulatory processes for medicines and medical devices, improving access to medicines, and ...
29 October 2014
Alere has agreed to sell its health services unit, Alere Health, to United Health subsidiary Optum for $600m in cash. The divestment is part of Alere’s ongoing restructuring after a troubled time: last year, a group of rebel shareholders tried – ...
 
30 October 2014
Abbott Laboratories, already among the most diversified major medtech companies, is now entering the electrophysiology space. With the acquisition of Topera Medical and the rights to buy Advanced Cardiac Therapeutics, Abbott is going after the ...
30 October 2014
Dutch molecular diagnostics specialist Qiagen posted an in-line third quarter, with sales of $336.8m and adjusted earnings of $0.27 per share bang on analyst consensus. However, the firm is facing a challenging human papillomavirus (HPV) testing ...
30 October 2014
Laboratory Corporation of America (LabCorp) had a solid third-quarter, according to Goldman Sachs’ Isaac Ro, again beating analyst predictions. Sales of $1.55bn grew 6% year-on-year and were above consensus of $1.50bn; while adjusted earnings of ...
29 October 2014
UK-based Danaher subsidiary Leica Biosystems has agreed to buy breast biopsy instrument specialist Devicor Medical Products from its private equity owner GTCR. Although financial terms were not disclosed, Jefferies analyst Brandon Couillard ...
 
30 October 2014
Just as NHS England hopes parliamentarians, opinion formers, decision makers, clinicians and patients all buy into the well-argued messages in its Five Year Forward View ( www.clinica.co.uk 23 October 2014), the UK medical technology industry hopes ...
30 October 2014
In the fifth instalment of Clinica’s new reimbursement series, Dr Mark Charny explains that careful and detailed consideration of the reimbursement, prescribing and purchasing regulations in each market is required to develop a coherent marketing ...
29 October 2014
A small group of experts is to conduct an independent assessment of Australia's Therapeutic Goods Administration with a view to streamlining the agency's regulatory processes for medicines and medical devices, improving access to medicines, and ...
28 October 2014
Turkey is facing a backlash from the medical device industry after the country’s public reimbursement agency, the Social Security Institution (SGK), released earlier this month new medtech pricing policies which would see reimbursement limits for ...
 
Amedica gets surgical expertise with new CEO Orthopedic firm Amedica has appointed existing chair and board member Sonny Bal president and CEO. He replaces Eric Olson, who has been heading up ...
Thoratec goes back to the future with CEO appointment Keith Grossman has retaken the helm of left-ventricular-assist-device manufacturer Thoratec after an eight-and-a-half year hiatus. Mr Grossman has ...
Insulet bags veteran Patrick Sullivan as new CEO Insulin pump specialist Insulet has appointed Patrick Sullivan CEO, with long-time leader Duane DeSisto retiring after 13 years with the firm. ...
23 October 2014
Ashley Yeo

For all the high regard in which the English NHS is held, domestically and, more dispassionately, outside the UK (eg the recent Commonwealth Fund ’s international health systems ranking), the consensus has long been that current and future ...

09 October 2014
Peter Charlish

Personalized medicine may not yet be a reality but, as a meeting of the Society for Medicines Research heard in London last week, considerable progress has nonetheless already been made towards that goal. In the UK, for example, a number of ...

 
23 October 2014
Ashley Yeo

For all the high regard in which the English NHS is held, domestically and, more dispassionately, outside the UK (eg the recent Commonwealth Fund ’s international health systems ranking), the consensus has long been that current and future ...

22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

09 October 2014
Peter Charlish

Personalized medicine may not yet be a reality but, as a meeting of the Society for Medicines Research heard in London last week, considerable progress has nonetheless already been made towards that goal. In the UK, for example, a number of ...

 
22 September 2014
Madeleine Armstrong

Many companies and researchers are trying to develop a blood test for Alzheimer’s disease – but Norway’s Pre Diagnostics is taking a different approach that it believes will give it the edge over its rivals. Clinica spoke to chief scientific officer ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
21 October 2014

Clinica’s Medtech Ventures: Origin Sciences Specialty area(s): Gastrointestinal disease detection and monitoring Based in: Cambridge, UK Founded in: 2004 No. of employees: 7 Total investment received to date:  £7.5m ($12.0m) Investors:  Animatrix ...

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
 
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36